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MEK and ERK are central components of the mitogen-activated protein kinase pathway. However, an 
accurate interaction has never been studied and accurate binding constants of the binary interaction have 
never been directly measured. In the present work, we studied the interaction between MEK and ERK by 
stopped-flow fluorescence intensity and evaluated the association and dissociation rate constants (kon and 10 
koff) from the kinetic study. We compared the results obtained by using commercial and homemade 
protein productions. The dissociation binding constant (Kd) value determined for the binding of MEK to 
ERK is in good agreement with the values obtained from the analysis of the kinase enzymatic reaction of 
previous in vitro studies. 
1. Introduction 15 
In the last two decades biological research has been focused on 
the exploration of the basis of cell regulation and function at 
molecular level. We now know that cell responses to external 
stimuli are determined by intracellular intricate signaling 
networks, which are composed of biochemical pathways based 20 
essentially on protein interactions. Despite considerable progress 
has been made, it is apparent that the flow of biological 
information has not yet been fully deciphered. In particular the 
abundance of qualitative information, concerning cellular 
interacting components, needs to be improved with sufficient 25 
availability of quantitative data. In this context, the set-up of 
approaches to provide high quality data in terms of the 
determination of kinetic parameters is needed to contribute to this 
kind of improvement. This is of special interest to systems 
biologists who deal with the development of kinetic model of 30 
intracellular signal transduction and often suffer from the lack of 
available kinetic parameters. 
 Central building blocks in the intracellular signalling networks 
are the mitogen-activated protein kinase (MAPK) cascades which 
are critical for cellular decision to proliferate, differentiate, or 35 
undergo apoptosis.1-3. MAPK cascades comprise several set of 
cytoplasmic protein kinases organized as modular pathways. The 
activation of upstream kinases by cell surface receptors leads to 
sequential activation of an evolutionarily conserved core module 
of protein kinases (MAPKKK  MAPKK  MAPK).4 The most 40 
widely characterized mammalian MAPK cascade is the 
Raf─MEK─ERK axis (Fig. 1) along which multiple isoforms are 
present at each level. Among them, two high related isoforms, 
MEK1/2 and ERK1/2 play a primary role in signal transduction. 
 Although the MAPK cascades have been the subject of intense 45 
research, there are few quantitative kinetic studies on the 
components belonging to this pathway. In particular the 
association and dissociation rate constants (i.e., kon and koff, 
respectively) for the binary protein-protein interactions in this 
cascade have been derived from simulation/prediction studies5,6 50 
or from in vitro studies of the kinase enzymatic reactions.7-9 
There is only one recent work10 in which the dissociation binding 
constants (Kd) concerning MAPK complexes have been estimated 
from measurements on living cells. Therefore in vitro accurate 
determination of the kinetic parameters seems to be necessary to 55 
provide a more complete knowledge, allowing a direct 
comparison with the data obtained by different methodologies at 
the same time. 
 Numerous techniques have been described and applied to 
characterize protein-protein interactions in vitro.11-13 These 60 
techniques are often specialized and frequently use proper 
fluorescent probes as versatile means for studying the kinetics of 
protein interactions. Stopped-flow fluorescence intensity method 
offers a powerful tool for detailed kinetic analysis of protein 
interactions and has gained considerable importance during the 65 
past few years.14 The main advantages of this technique are the 
following: (i) the reaction can be monitored continuously in real 
time over a broad range of reactant concentrations at the 
millisecond time scale; (ii) the system operates in a liquid 
environment where the interacting molecules are not bound to a 70 
solid support, this provides a more physiological condition of 
work, minimizing possible measurement alterations due to 
conformational changes that could arise from the protein-support 
binding; (iii) the experiments are not time-consuming. 
 The present study reports the kinetic investigation of the 75 
interaction between MEK and ERK by stopped-flow fluorescence 
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Fig. 1 Network topology of the mammalial MAP Kinases cascade: 
Raf/MEK/ERK axis. The signaling via this cascade, is usually initiated by 
growth factor receptor (GFR) activation, which transmit the signal by 
activating the MAPKKK, Raf-1. Active Raf-1 binds and activates the 
MAPKK, MEK (two isoforms, MEK1/2), by phoshorylation. Following a 5 
similar process, active MEK binds and activates the MAPK, ERK (two 
isoforms, ERK1/2). Active ERK regulates various cellular processes such 
as proliferation, differentiation, survival, and apoptosis. The network 
topology was realized using Cell Designer software according to Systems 
Biology Graphical Notation.33 10 
 
intensity. The experimental procedure was based on the 
bioconjugation of ERK with a proper fluorophore, i.e. 
fluorescein-5-maleimide, followed by the analysis of its 
interaction with MEK by stopped-flow. This approach was 15 
applied to study the interaction of both commercial and 
homemade recombinant MEK and ERK proteins. Here kinetic 
values for the koff and kon of MEK-ERK binding have been 
experimentally measured for the first time avoiding their 
derivation from the analysis of the kinase enzymatic reaction. 20 
From the koff/kon ratio we calculated the corresponding Kd value 
that was compared with those obtained by previous studies. 
2. Experimental Procedures 
2.1 Reagents 
The commercial recombinant MEK and ERK proteins used were 25 
full-length active MEK1 and full-length unactive ERK1. MEK1 
was purchased from Upstate® as N-terminal GST and C-terminal 
6His-tagged, expressed in E. coli, purified using glutathione-
agarose followed by Ni2+/NTA-agarose, activated using c-Raf 
and re-purified using Ni2+/NTA-agarose; purity 98%; MW = 71 30 
kDa. ERK1 was purchased from Upstate® as N-terminal 
Glutathione S-transferase (GST)-tagged protein, expressed in E. 
coli and purified using glutathione-agarose; purity 97%; MW = 
70 kDa. The homemade recombinant MEK and ERK proteins 
used were the constitutively active mutant MEK1 R4F 35 
(containing an N-terminal deletion of aa 32-51 and the 
Ser218Glu/Ser222Asp substitutions) and full-length unactive 
ERK2; both the proteins were produced in the laboratory of the 
authors as follows. MEK1 R4F and ERK2 were expressed in the 
BL21-DE3 strain of E. coli transformed with pGEX-KG MEK1 40 
R4F and NpT7-5 ERK2, respectively. MEK1 R4F (expressed as 
GST-fusion protein; MW = 66 kDa) and ERK2 (expressed with 
6His-tag; MW = 42 kDa) were purified as described in detail 
previously;15 minimum 90% purity as determined by Sodium 
Dodecyl Sulphate-PolyAcrylamide Gel Electrophoresis (SDS-45 
PAGE) and Coomassie blue (Bio-Safe Coomassie, Bio-Rad) 
staining. Purified MAP Kinases were dialyzed against Dulbecco’s 
Phosphate-Buffered Saline (PBS; BE17-512F; 
BioWhittaker/Cambrex) using Slide-A-Lyzer 3.5K (PIERCE). 
MEK1 R4F and ERK2 concentrations were determined after 50 
resolving recombinant protein samples and dilution series of 
purified 2mg/ml bovine serum albumin by SDS-PAGE and 
staining with Coomassie blue; the gels were then documented 
using ChemiDoc XRS charged-coupled device (Bio-Rad) and the 
proteins were quantified using Quantitative One software (Bio-55 
Rad). 
 ERK2 and MEK1 R4F expression plasmids were a generous 
gift of Melanie Cobb (University of Texas, Southwestern) and 
Natalie Ahnn (University of Colorado, Boulder), respectively. 
 Fluorescein-5-maleimide was synthesised as reported 60 
previously.16 
2.2 Bioconjugation 
ERK proteins have been bioconjugated with fluorescein-5-
maleimide  following the reported protocol.17,18 ERK 
concentration was 0.4 mg/ml and the excess of fluorescein-5-65 
maleimide used was 50-fold. After bioconjugation, the derivative 
was immediately purified using Sephadex® G-25 desalting 
column (Amersham Bioscience) and PBS (pH=7.4) as eluent. 
2.3 Calculation of Dye/Protein ratio 
To evaluate the fluorophore labeling efficiency, the dye/protein 70 
ratios (D/P) of the conjugates were determined by the absorption 
spectra of the labeled proteins, registered in PBS (pH=7.4) 
according to the relationship reported in eqn (1): 
    
 75 
 
 
 
where A280 is the absorption of the conjugate at 280 nm; Amax is 
the absorption of the conjugate at the absorption maximum of the 80 
corresponding fluorescein-5-maleimide; c is a correction factor 
which must be used to adjust for amount of A280 contributed by 
the dye because fluorescent dyes also absorb at 280 nm and 
equals the A280 of the dye divided by the Amax of the dye (c = 
0.29); εprot (42230 cm−1 M−1) and εdye (63096 cm−1 M−1) are the 85 
molar extinction coefficients for the protein used and fluorescein-
5-maleimide, respectively. The evaluation of c, εdye and εprotein 
were calculated as reported elsewhere.19,20 
dye
prot
cAA
A
PD
ε
ε
⋅−
⋅
= )(/ max280
max (1) 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  3 
 ERK presents ten cysteine residues and the resulting D/P 
value was 0.98 for both commercial and homemade proteins on 
the basis of three averaged bioconjugations. 
2.4 Experimental techniques 
UV-Vis measurements for the evaluation of the fluorophore 5 
labeling efficiency were recorded using a Shimadzu UV-1700 
Pharma Spec Spectrophotometer equipped with 1.0 cm path 
length quartz cells. 
 Fluorescence kinetics measurements were recorded using an 
Applied Photophysics SX20 stopped-flow spectrometer fitted 10 
with a 515 nm cut-off filter between the cell and fluorescence 
detector and equipped with a thermostat bath (30°C). Data 
acquisition, visualisation and analysis were provided by Pro-Data 
software from Applied Photophysics Ltd. 
2.5 Experimental procedures 15 
Biolabelled ERK concentration (10 nM in PBS) was kept 
constant and several shots of different MEK concentrations were 
performed: 100 nM, 120 nM, 140 nM and 160 nM in PBS for the 
commercial proteins. For homemade production, the chosen 
MEK concentrations were: 20 nM, 40 nM, 60 nM, 100 nM and 20 
130 nM. The reported concentrations are syringe concentrations, 
this means that the real concentrations in the cuvette are halved. 
Each experiment (whole concentration set) was repeated five 
times, each time using a new mother solution and a different set 
of protein production. For each dilution condition at least five 25 
scans were acquired and averaged. Each experimental point is 
therefore an average of 25 shots. Raw data were analyzed and 
plotted to a single exponential function by using Pro-Data Viewer 
4.0.17 and from this data treatment the observed rate constants 
(kobs) were obtained. The excitation wavelength was 495 nm and 30 
slits widths of the excitation monochromator were 0.2 mm. 
 The displacement experiment was performed according to 
Eccleston et al.21 A solution containing a mixture of 50 nM 
biolabelled ERK with 50 nM MEK was rapidly mixed with a 
large excess (400 nM) of unlabelled ERK. The displacement was 35 
repeated four times and the koff obtained is an averaged value of 
these four experiments. 
3. Results 
To study the interaction between MEK and ERK we firstly used 
the commercial proteins. The binary protein binding was 40 
investigated under pseudo-first order conditions (i.e., [MEK] >> 
[ERK]). Fig. 2 shows that on mixing 10 nM ERK with 120 nM 
MEK there is a decrease in fluorescence intensity which can be 
well fitted to give a rate constant of 12.49 s-1. 
 The dependence of the kobs for MEK-ERK binding was 45 
investigated using 10 nM biolabelled ERK and the range of 100-
160 nM MEK (Fig. 3). In these experimental settings, the values 
of the kinetic parameters can be calculated from the slopes and 
intercepts of the linear plots of kobs versus increasing 
concentration of MEK (see eqn 2). 50 
     
 
 
 
Fig. 2 (A) Stopped-flow fluorescence intensity record of the binding of 55 
120 nM MEK  to 10 nM ERK  (commercial proteins). The solid thin line 
is the best fit to the data giving rate constants of 12.49 s-1. (B) Residuals 
are also reported. 
 
               60 
 
Fig. 3  Dependence of the kobs determined by fluorescence intensity of the 
binding of ERK to increasing MEK concentrations (commercial proteins). 
Data points are the mean of five independent experiments ± standard 
deviation. Error bars not visible are concealed by the data point. 65 
 
 In particular, the slope of the straight line is the kon (second-
order rate constant; units, M-1 sec-1) and the intercept on the 
ordinate is the koff (first-order rate constant; units, sec-1). The 
second-order rate constant kon is 5.49·108 M-1s-1. As it can be 70 
seen, the intercept on the ordinate has a small negative value (-24 
sec-1). This shows that the interaction is nearly completely shifted 
toward the formation of the complex. 
 
[ ] offonobs kMEKkk += (2) 
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Fig. 4 Dependence of the kobs determined by fluorescence intensity of the 
binding of ERK to increasing MEK concentrations (homemade proteins). 
Data points are the mean of five independent experiments ± standard 
deviation. Error bars not visible are concealed by the data point. 5 
 
sec-1). This shows that the interaction is nearly completely shifted 
toward the formation of the complex. 
 To further investigate this aspect, we then used more cheap 
homemade proteins in order to perform other interactions and to 10 
carefully evaluate the koff value. The interaction was repeated and 
the dependence of the kobs for MEK-ERK binding was again 
investigated using 10 nM biolabelled ERK and a range of 20-130 
nM MEK (Fig. 4). The slope of the straight line through the 
points gives the apparent kon value and this is estimated to be 15 
3.23·108 M-1s-1 which is in good accordance with the previous 
value obtained with commercial proteins. The intercept of the 
straight line with the y-axis should give the koff value, but again it 
cannot be reliably distinguished from zero with the obtained data. 
It should be noted that there will be a significant error on the 20 
points at low concentrations, since true pseudo-first-order 
conditions did not prevail. The intercept would not be reliable 
even if seen to be finite but small. 
 Since disassociating rate constant value seems to be small, 
obtained koff is not reliable. To gain more information and to 25 
measure koff value accurately, a displacement experiment was 
executed as proposed previously.21 Briefly, in the displacement 
experiment (see Scheme 1), a solution containing fluorescent 
ERK (ERK-fL) and MEK is mixed with an excess of non-
fluorescent ERK (ERK-nfL). The concentration of ERK-fL is 30 
chosen to get a saturation of MEK, and then a high concentration 
of ERK-nfL is added so that ERK-fL dissociates from MEK and 
cannot reassociate. In this way the rate constant of the observed 
process is determined only by k
-1. 
 The koff value was therefore measured directly by 35 
displacement of ERK from its complex with MEK using an 
excess of unlabeled ERK. Fluorescence intensity was monitored 
during the process and the corresponding record was fitted to give  
an averaged rate constant of 18.7 s-1 (Fig. 5). This koff value 
together with that obtained for the kon allowed us to calculate the 40 
Kd value of 58 nM for MEK-ERK interaction. This is in excellent 
agreement with the Kd value of 50 nM obtained by steady-state 
fluorescence in the same buffer (data not shown). 
 
 45 
Scheme 1 Displacement reaction. 
 
Fig. 5 Stopped-flow fluorescence record of a representative displacement 
experiment (homemade proteins): one syringe contained 50 nM 
biolabelled ERK, 50 nM MEK, and the other syringe contained 400 nM 50 
unlabelled ERK. The plot shows a fit to a single exponential with a rate 
constant of 20.5 s-1. The experiment was repeated four times and the 
averaged obtained value is 18.7 s-1 ± 2.2. 
4. Discussion 
In the present work, the binding between MEK and ERK, two 55 
members of a crucial intracellular signal pathway, was studied by 
stopped-flow fluorescence intensity. The values of kon and koff 
were experimentally measured for the first time avoiding their 
derivation from the analysis of the kinase enzymatic reaction. The 
Kd value was determined from the koff/kon ratio and results to be 60 
in excellent agreement with the values obtained in previous in 
vitro studies.8,9 This shows that the use of stopped-flow technique 
is a suitable approach for studying protein-protein interactions in 
vitro. 
 A careful collection of available information, relative to the 65 
kinetic parameter for MEK-ERK interaction, allowed us to 
compare the values obtained with those previously found by 
different methods (Table 1). In fact, the Kd value reported is of 
the same order of magnitude of that obtained by deriving kon and 
koff from the in vitro study of the kinase enzymatic reaction.7-9 70 
Compared to those obtained by in vitro methods, the Kd values 
derived from simulation modeling by the group of Schoeberl5 and 
Yamada7 result to be one and two order of magnitude different, 
respectively. The in vitro Kd value results to be one order of 
magnitude different from that obtained in vivo by Fujioka and co-75 
workers.10 The authors calculated the half-life of the MEK-ERK 
complex, and estimated the dissociation rates from these half-
lives. 
 
Table 1 Parameters for MEK-ERK interaction. 80 
 
references method kon (106 M-1 s-1) koff  (s-1) Kd (nM) 
This study in vitro  323  18.7 58 
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Bhalla 2004a,8, 
Sasagawa et al. 
2005a,9 
in vitro 16.2  0.6 37 
Fujioka et al. 
200610 
in vivo  0.88  0.088  100
 
Schoeberl et al. 
20025 
simulation 
modeling 
0.11  0.033 300 
Yamada et al. 
20046 
simulation 
modeling 
0.318  0.9 2800 
aConsidering the Michaelis-Menten formulation as a special case of two 
reactions in sequence (Bhalla & Iyengar 1999), the values corresponding 
to Km, kcat and koff/kcat ratio (available in the DOQS database, 
http://doqcs.ncbs.res.in) for MEK-ERK kinase enzymatic reaction 
allowed the derivation of the values corresponding to kon, koff and Kd for 
MEK-ERK binding. 
 
 In the context of protein-protein interaction it is well 
established that the in vitro study requires in vivo validation, and 
vice versa. Measures performed in living cells have to be 
considered of high value due to the physiological/cellular context 5 
in which molecules operate. On the other hand, in vitro methods 
analyze binary protein-protein interactions in a cell free system, 
which is characterized by the absence of positive or negative 
influence exerted by additional molecular determinants which 
could be present in vivo. Therefore, significant discrepancies may 10 
arise from the two approaches. Apparently any remarkable 
difference in the readout is daunting. Indeed, if it occurs, it may 
be considered as an indication of a possible gap in the biological 
information and therefore this suggestion may be considered as 
useful. Taking into account these considerations, we may attempt 15 
to speculate on the comparison between the Kd values obtained in 
vitro and the value derived from the in vivo study reported by 
Fujioka and coworkers. The observed difference in one order of 
magnitude among these Kd may be due to the diverse activation 
state of MEK as well as the presence of additional factors 20 
regulating MEK-ERK interaction in vivo. Indeed, as reported by 
the group of Fujioka,10 only a fraction of MEK is activated in 
vivo, even when ERK activation is saturated, whereas all of the 
MEK is in the activated form in vitro. In addition, a number of 
evidence suggests the emerging role of scaffold proteins as 25 
regulators of MAPK signaling kinetics in terms of both 
potentiation and attenuation.22-24 
 It is well known that MEK-ERK interaction and signaling 
represents a complex signal module that may be controlled by 
different regulatory mechanisms. MEK is activated by 30 
phosphorylation of two Ser residues (Ser218 and Ser222 in 
MEK1; Ser222 and Ser226 in MEK2), and in turn binds and 
activates ERK by dual phosphorylation on Thr and Tyr residues 
(Thr202 and Tyr204 in ERK1; Thr185 and Tyr187 in ERK2). 
Moreover, inactive MEK can also bind (albeit weakly) to ERK 35 
and the phosphorylation of additional MEK amino acid residues 
have been reported in literature to have positive and negative 
effects on ERK phosphorylation and signaling.25-27 Therefore, 
one may speculate that the different phosphorylated residues play 
a role in regulating MEK-ERK binding affinity. 40 
 Interestingly, it is a controversial issue whether 
phosphorylation of ERK by MEK is a processive or distributive 
mechanism. In a processive catalysis, after binding the substrate, 
the kinase carries out two phosphorylation before releasing the 
final product; in contrast, in a distributive mechanism, the 45 
enzyme releases the intermediate monophosphorylated products, 
and a new collision is required for the conversion of this 
intermediate into the final product.28 However, a number of 
evidence demonstrates that dual phosphorylation of MAPKs 
occurs through a distributive two-collision mechanism.29-31 In this 50 
case, the Kd values that we calculated from our in vitro 
measurements would represent the Kd corresponding to MEK-
ERK complex formation that precedes the first step of the 
distributive mechanism of catalysis. Interestingly, the obtained Kd 
value is in excellent agreement with the corresponding value (50 55 
nM) that is possible to calculate from the kon and koff reported by 
Markevich et al.28 They developed a computational model of 
MAPK signaling based on parameter values retrieved from 
previously reported experimental data on the time course of 
MEK-catalyzed dual phosphorylation of ERK. For a future 60 
detailed characterization of MEK-ERK binding in this context, it 
will be interesting to analyze the interaction between MEK and 
monophosphorylated ERK using the proposed stopped-flow 
approach and compare the derived data with those reported in the 
case of MEK binding to unphosphorylated ERK. 65 
 A recent study by Baccarini et al. reports that MEK1-MEK2 
heterodimers exist in the cells, and that they coesist with MEK1 
and MEK2 monomers, with higher order complexes and possibly 
with homodimers.32 In this context, the role of heterodimer 
formation has been shown to be essential for ERK-mediated 70 
phosphorylation of Thr292 of MEK1, that attenuates MEK/ERK 
signaling through a negative feed-back mechanism.32 
Conclusions 
Through the case study of MEK-ERK binding, we propose the 
stopped-flow approach as a suitable in vitro method to 75 
experimentally measure the kinetic parameters of binary protein-
protein binding in a well-characterized and not time-consuming 
manner. This is of particular importance in the development of 
signal transduction mathematical models, in which the systems 
biologists are often faced with the difficulties concerning the 80 
choice of the kinetic constant values to be used in the model of 
interest. A more intensive use of stopped-flow fluorescence 
intensity technique may facilitate the generation of high-quality 
in vitro data. Having established a framework for deriving such 
valuable data, the natural extension of our work may consist in 85 
the kinetic analysis from a biological standpoint more closely to 
the real complex systems of MAPK cascade. This may be 
achieved by investigating the in vitro MEK-ERK interaction 
considering homodimer vs heterodimer formation as well as the 
presence/absence of specific phosphorylated amino acid residues 90 
in the recombinant proteins of interest. 
 Finally, the stopped-flow approach that we proposed may be 
applied in the context of binary protein-protein interaction 
belonging to other signaling cascades and contribute to a better 
comparison between in vitro and in vivo protein interaction 95 
behaviors, leading to an improvement in the development of 
signal transduction models for a fine elucidation of cell signaling 
mechanisms. 
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